GR-127935

From WikiMD's WELLNESSPEDIA

Chemical structure of GR-127935

GR-127935 is a chemical compound that acts as a selective antagonist of the 5-HT1B receptor and 5-HT1D receptor. It is primarily used in scientific research to study the role of these receptors in various physiological and pathological processes.

Pharmacology[edit]

GR-127935 is known for its high affinity and selectivity for the serotonin receptor subtypes 5-HT1B and 5-HT1D. These receptors are part of the larger family of G protein-coupled receptors (GPCRs) and are involved in the modulation of neurotransmitter release, particularly serotonin.

Mechanism of Action[edit]

As an antagonist, GR-127935 binds to the 5-HT1B and 5-HT1D receptors, preventing the action of endogenous serotonin. This blockade can help elucidate the physiological roles of these receptors, such as their involvement in migraine pathophysiology and vasoconstriction.

Research Applications[edit]

GR-127935 is widely used in neuroscience research to investigate the function of 5-HT1B and 5-HT1D receptors. Studies have utilized this compound to explore its effects on behavioral neuroscience, pain management, and psychiatric disorders.

Migraine Studies[edit]

Research has shown that GR-127935 can be used to study the mechanisms underlying migraine headaches. By blocking the 5-HT1B and 5-HT1D receptors, researchers can better understand the role of serotonin in migraine attacks and develop potential therapeutic strategies.

Behavioral Studies[edit]

In behavioral studies, GR-127935 has been used to assess the role of serotonin in anxiety, depression, and aggression. The compound's ability to selectively block specific serotonin receptors makes it a valuable tool for dissecting the complex serotonergic pathways involved in these behaviors.

Chemical Properties[edit]

GR-127935 is a small molecule with a specific chemical structure that allows it to interact selectively with its target receptors. The structure of GR-127935 is depicted in the image to the right, highlighting its key functional groups responsible for receptor binding.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=GR-127935&oldid=6626554"